ADIPOQ and prostate carcinoma: However, there was some evidence of asymmetry in studies of aggressive prostate cancer; for leptin this asymmetry was to the right, or towards positive associations in smaller studies, and for adiponectin this was to the left, or towards inverse associations in smaller studies.